AF
MRNA icon

Allworth Financial’s Moderna MRNA Stock Holding History

Allworth Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Sell
4,123
-245
-6% -$12.7K ﹤0.01% 1279
2026
Q1 		$222K Buy
4,368
+1,185
+37% +$55.3K ﹤0.01% 1336
2025
Q4 		$93.9K Sell
3,183
-1,446
-31% -$39.3K ﹤0.01% 1795
2025
Q3 		$120K Buy
4,629
+804
+21% +$22.4K ﹤0.01% 1582
2025
Q2 		$106K Buy
3,825
+1,627
+74% +$42.8K ﹤0.01% 1516
2025
Q1 		$60.2K Buy
2,198
+297
+16% +$10.5K ﹤0.01% 1468
2024
Q4 		$73.2K Buy
1,901
+281
+17% +$13.4K ﹤0.01% 1400
2024
Q3 		$108K Sell
1,620
-213
-12% -$19.6K ﹤0.01% 1050
2024
Q2 		$222K Buy
1,833
+122
+7% +$15.4K ﹤0.01% 783
2024
Q1 		$182K Buy
1,711
+51
+3% +$5.14K ﹤0.01% 815
2023
Q4 		$165K Buy
1,660
+101
+6% +$8.49K ﹤0.01% 777
2023
Q3 		$161K Buy
1,559
+49
+3% +$5.47K ﹤0.01% 742
2023
Q2 		$183K Sell
1,510
-322
-18% -$43K ﹤0.01% 724
2023
Q1 		$281K Sell
1,832
-162
-8% -$26.7K ﹤0.01% 581
2022
Q4 		$358K Buy
1,994
+542
+37% +$88.6K ﹤0.01% 528
2022
Q3 		$172K Sell
1,452
-328
-18% -$49.8K ﹤0.01% 625
2022
Q2 		$254K Buy
1,780
+60
+3% +$8.58K ﹤0.01% 518
2022
Q1 		$296K Buy
1,720
+515
+43% +$86.7K ﹤0.01% 475
2021
Q4 		$306K Sell
1,205
-187
-13% -$54.7K ﹤0.01% 448
2021
Q3 		$536K Buy
1,392
+96
+7% +$35.4K 0.01% 320
2021
Q2 		$305K Sell
1,296
-371
-22% -$66.3K 0.01% 316
2021
Q1 		$218K Buy
1,667
+85
+5% +$12.3K ﹤0.01% 342
2020
Q4 		$165K Buy
1,582
+952
+151% +$96.3K ﹤0.01% 302
2020
Q3 		$45K Buy
630
+40
+7% +$2.79K ﹤0.01% 437
2020
Q2 		$38K Buy
590
+40
+7% +$2.19K ﹤0.01% 466
2020
Q1 		$16K Buy
+550
New +$12.7K ﹤0.01% 602

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Allworth Financial's MRNA Position: Q2 2026 in Review

Allworth Financial reduced its Moderna (MRNA) stake by 5.6% in Q2 2026, selling an estimated $12.7K and leaving 4,123 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1279.

Allworth Financial first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $536K in Q3 2021. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Allworth Financial held 4,123 shares of Moderna worth $289K as of Q2 2026.
  • Allworth Financial sold 245 Moderna shares in Q2 2026, an estimated $12.7K.
  • Moderna made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1279 holding.
  • Allworth Financial first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • Allworth Financial's Moderna position peaked at $536K in Q3 2021.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.